0.37 USD
↗ 0.03 (8.65%)LIVE (AS OF 12:39 PM EDT)
Theriva Biologics, Inc.
TOVXAMEX • USD
Market: OPEN
Open?$0.32
High?$0.37
Low?$0.31
Prev. Close?$0.34
Volume?14.0M
Avg. Volume?40.4M
VWAP?$0.34
Rel. Volume?0.35x
Bid / Ask
Bid?$0.36 × 1.0K
Ask?$0.36 × 8.0K
Spread?$0.00
Midpoint?$0.36
Valuation & Ratios
Market Cap?15.6M
Shares Out?45.9M
Float?33.4M
Float %?98.9%
P/E Ratio?N/A
P/B Ratio?1.01
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.74Adequate
Quick Ratio?1.74Adequate
Cash Ratio?1.30Strong
Debt/Equity?0.11Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.01CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-164.1%WEAK▾
ROA?-66.0%WEAK▾
Cash Flow & Enterprise
FCF?$-16704000
Enterprise Value?$4.3M
News
Profile
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
Employees
16
Market Cap
18.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1993-04-05
Address
9605 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Phone: (734) 332-7800
ROCKVILLE, MD 20850
Phone: (734) 332-7800